» Articles » PMID: 36843390

DNA Methylation-based Classification of Glioneuronal Tumours Synergises with Histology and Radiology to Refine Accurate Molecular Stratification

Abstract

Aims: Glioneuronal tumours (GNTs) are poorly distinguished by their histology and lack robust diagnostic indicators. Previously, we showed that common GNTs comprise two molecularly distinct groups, correlating poorly with histology. To refine diagnosis, we constructed a methylation-based model for GNT classification, subsequently evaluating standards for molecular stratification by methylation, histology and radiology.

Methods: We comprehensively analysed methylation, radiology and histology for 83 GNT samples: a training cohort of 49, previously classified into molecularly defined groups by genomic profiles, plus a validation cohort of 34. We identified histological and radiological correlates to molecular classification and constructed a methylation-based support vector machine (SVM) model for prediction. Subsequently, we contrasted methylation, radiological and histological classifications in validation GNTs.

Results: By methylation clustering, all training and 23/34 validation GNTs segregated into two groups, the remaining 11 clustering alongside control cortex. Histological review identified prominent astrocytic/oligodendrocyte-like components, dysplastic neurons and a specific glioneuronal element as discriminators between groups. However, these were present in only a subset of tumours. Radiological review identified location, margin definition, enhancement and T2 FLAIR-rim sign as discriminators. When validation GNTs were classified by SVM, 22/23 classified correctly, comparing favourably against histology and radiology that resolved 17/22 and 15/21, respectively, where data were available for comparison.

Conclusions: Diagnostic criteria inadequately reflect glioneuronal tumour biology, leaving a proportion unresolvable. In the largest cohort of molecularly defined glioneuronal tumours, we develop molecular, histological and radiological approaches for biologically meaningful classification and demonstrate almost all cases are resolvable, emphasising the importance of an integrated diagnostic approach.

Citing Articles

cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics.

Aldape K, Capper D, von Deimling A, Giannini C, Gilbert M, Hawkins C Neurooncol Adv. 2025; 7(1):vdae228.

PMID: 39902391 PMC: 11788596. DOI: 10.1093/noajnl/vdae228.


Phenotypic and epigenetic heterogeneity in FGFR2-fused glial and glioneuronal tumours.

Metais A, Dangouloff-Ros V, Garcia J, Vannod-Michel Q, Csanyi M, Tauziede-Espariat A Neuropathol Appl Neurobiol. 2024; 50(6):e13014.

PMID: 39511841 PMC: 11618513. DOI: 10.1111/nan.13014.


Paediatric low-grade glioma: the role of classical pathology in integrated diagnostic practice.

Stone T, Merve A, Valerio F, Yasin S, Jacques T Childs Nerv Syst. 2024; 40(10):3189-3207.

PMID: 39294363 PMC: 11511714. DOI: 10.1007/s00381-024-06591-6.


Clinical, pathologic, and genomic characteristics of two pediatric glioneuronal tumors with a CLIP2::MET fusion.

Chapman N, Greenwald J, Suddock J, Xu D, Markowitz A, Humphrey M Acta Neuropathol Commun. 2024; 12(1):63.

PMID: 38650040 PMC: 11036580. DOI: 10.1186/s40478-024-01776-1.


Neuropathology and epilepsy surgery - 2024 update.

Blumcke I Free Neuropathol. 2024; 5.

PMID: 38532826 PMC: 10964794. DOI: 10.17879/freeneuropathology-2024-5347.


References
1.
Capper D, Stichel D, Sahm F, Jones D, Schrimpf D, Sill M . Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol. 2018; 136(2):181-210. PMC: 6060790. DOI: 10.1007/s00401-018-1879-y. View

2.
Fukuoka K, Mamatjan Y, Tatevossian R, Zapotocky M, Ryall S, Stucklin A . Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas. Neuro Oncol. 2020; 22(10):1474-1483. PMC: 7566385. DOI: 10.1093/neuonc/noaa077. View

3.
Aryee M, Jaffe A, Corrada-Bravo H, Ladd-Acosta C, Feinberg A, Hansen K . Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014; 30(10):1363-9. PMC: 4016708. DOI: 10.1093/bioinformatics/btu049. View

4.
Southwell D, Garcia P, Berger M, Barbaro N, Chang E . Long-term seizure control outcomes after resection of gangliogliomas. Neurosurgery. 2012; 70(6):1406-13. DOI: 10.1227/NEU.0b013e3182500a4c. View

5.
George S, Izquierdo E, Campbell J, Koutroumanidou E, Proszek P, Jamal S . A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations. Eur J Cancer. 2019; 121:224-235. PMC: 6839402. DOI: 10.1016/j.ejca.2019.07.027. View